Abnormal uterine bleeding is the most common problems to discontinue Depo-medroxyprogesterone acetate (DMPA) in Thailand. This clinical trial use to provide drug to stop abnormal uterine bleeding from DMPA
Abnormal uterine bleeding is the most common problems to discontinue Depo-medroxyprogesterone acetate (DMPA) in Thailand. After discontinue DMPA, patients have not used any method. Unwanted pregnancy are rising. The reason of abnormal uterine bleeding from DMPA aren't clearly understand. In present, no standard treatment to treat abnormal utrerine bleeding in DMPA users.This clinical trial use to provide drug to stop abnormal uterine bleeding from DMPA with minimal dose and minimal side effect
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
52
Compare between tranexamic acid and progynova to stop abnormal uterine bleeding in DMPA users
Compare between tranexamic acid and progynova to stop abnormal uterine bleeding in DMPA users
Krittiporn Mahachiraphat
Bangkok, Ratchathewi, Thailand
RECRUITINGKrittiporn Mahachiraphat, M.D.
Phaya Thai, Ratchathewi, Thailand
NOT_YET_RECRUITINGDay to stop abnormal uterine bleeding between groups after receiving Tranexamic acid and estrogen
To Compare day to stop abnormal uterine bleeding between groups after receiving Tranexamic acid and estrogen
Time frame: 1 week after intervention
Side effect after receiving Tranexamic acid
To study side effect after receiving Tranexamic acid
Time frame: 1 week after intervention
Side effect after receiving estrogen
To study side effect after receiving estrogen
Time frame: 1 week after intervention
Frequency of bleeding after DMPA injection
To study frequency of bleeding after DMPA injection
Time frame: after DMPA injection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.